PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
1.540
-0.150 (-8.88%)
Jun 5, 2026, 4:00 PM EDT - Market closed
PMGC Holdings Employees
As of December 31, 2025, PMGC Holdings had 34 total employees, including 32 full-time and 2 part-time employees. The number of employees increased by 31 or 1,033.33% compared to the previous year.
Employees
34
Change (1Y)
31
Growth (1Y)
1,033.33%
Revenue / Employee
37.41K LKR
Profits / Employee
-326.67K LKR
Market Cap
7.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 34 | 31 | 1,033.33% | 32 | 2 |
| Dec 31, 2024 | 3 | -15 | -83.33% | 2 | 1 |
| Dec 31, 2023 | 18 | 4 | 28.57% | 18 | 0 |
| Jun 30, 2023 | 16 | - | - | 16 | 0 |
| Mar 31, 2023 | 14 | - | - | 14 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 20 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| CNS Pharmaceuticals | 8 |
| Quoin Pharmaceuticals | 6 |
| Enveric Biosciences | 6 |
| Acurx Pharmaceuticals | 4 |
ELAB News
- 6 days ago - PMGC to buy 76% interest in precision machining, contract manufacturing company - TheFly
- 6 days ago - PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets - GlobeNewsWire
- 20 days ago - GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc. - GlobeNewsWire
- 23 days ago - PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year - GlobeNewsWire
- 25 days ago - PMGC acquires A&B Aerospace, terms undisclosed - TheFly
- 25 days ago - PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc. - GlobeNewsWire
- 5 weeks ago - UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders - GlobeNewsWire
- 5 weeks ago - NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans - GlobeNewsWire